Expanding Peptide Therapy Access

PEPTIDE COMPOUNDING INSIGHTS Expanding Access to Peptide Therapies

Access What Your Patients Need, When It Matters

We’re focused on expanding access to peptide therapies through compounded formulations, backed by trusted, reliable sourcing and a commitment to quality at every step of compounding.

Not All Peptides Are Prepared the Same

Not all peptides are created or handled the same way. Compounded medications are prepared within regulated pharmacy environments, following defined standards for sourcing, preparation, and quality controls.

Empower is your peptide partner, grounded in quality and compliance:

PCAB®-accredited
USP quality ingredients from FDA-registered sources
USP <795>, <797>, and <800> compliant practices
Third-party tested for quality and consistency
Stability studies supporting beyond-use dating
Dedicated Medical Affairs support

FDA Provided Clarity on GHK-Cu

On May 14, 2026, the FDA restored non-injectable GHK-Cu to Category 1 of the 503A bulk drug substances list, confirming that the earlier withdrawal applied only to injectable routes of administration. Injectable GHK-Cu remains under separate review. This means compounders may continue working with GHK-Cu for topical and other non-injectable applications under the current interim policy.

Empower currently offers two compounded GHK-Cu topical preparations: the GHK-Cu Facial Serum and the GHK-Cu Scalp Solution, both available through our 503A compounding pharmacy with a valid prescription.

EXPAND YOUR KNOWLEDGEPeptide Resource Hub

On-Demand Webinar

Peptide therapy has moved from niche biohacking circles into mainstream medicine, and the regulatory landscape around it is actively evolving. In Peptide Therapy: Where Do We Go From Here?, Shaun Noorian (Empower Pharmacy), Dr. Rekha Kumar (Found), and Dr. Alex Tatem (U.S. Urology) came together following that decision to discuss what this means for peptide access, with moderator Christina Farr (Second Opinion). The full conversation is now available on demand.

WATCH ON-DEMAND

Educational Articles

Stay current on peptide therapy with articles from our Knowledge Center. Get provider-focused insights on trends and the compounding industry to support informed conversations with your patients.

VIEW ARTICLES

Listen to a Podcast

On the Peptides for Women podcast, Senior Director, Medical Affairs Jean Cunningham, PharmD, BCPS breaks down what 503A and 503B compounding pharmacies actually do, and the risks of unregulated peptide sourcing.

LISTEN NOW